However, variants in DCTN1 do not segregate families with disease, indicating that they are not a primary cause for ALS, PD and FTD risk and potentially have either low disease penetrance or instead act as disease modifiers [79]. This evidence concerns the gene DCTN1 and Parkinson disease.